Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
J Antimicrob Chemother. 2008 Apr;61(4):919-24. doi: 10.1093/jac/dkn013. Epub 2008 Jan 31.
J Antimicrob Chemother. 2008.
PMID: 18238889
Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b.
De Blasi T, Aguilar Marucco D, Cariti G, Maiello A, De Rosa FG, Di Perri G.
De Blasi T, et al.
Infection. 2008 Jun;36(3):285-7. doi: 10.1007/s15010-007-6299-1. Epub 2007 Oct 25.
Infection. 2008.
PMID: 17962905
Item in Clipboard
Is a 3-month course of treatment with Peg-interferon effective in acute HCV hepatitis?
Cariti G, Quaglia S, Meoli I, Veronese L, Audagnotto S, De Blasi T, Mancardi E, Raiteri R, Di Perri G.
Cariti G, et al. Among authors: de blasi t.
J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):188-90.
J Biol Regul Homeost Agents. 2003.
PMID: 14518721
Clinical Trial.
Item in Clipboard
A short course of pegylated interferon-alpha in acute HCV hepatitis.
Calleri G, Cariti G, Gaiottino F, De Rosa FG, Bargiacchi O, Audagnotto S, Quaglia S, De Blasi T, Romano P, Traverso A, Leo G, Carbone R, Del Mastro B, Tinelli M, Caramello P, Di Perri G.
Calleri G, et al. Among authors: de blasi t.
J Viral Hepat. 2007 Feb;14(2):116-21. doi: 10.1111/j.1365-2893.2006.00802.x.
J Viral Hepat. 2007.
PMID: 17244251
Clinical Trial.
Item in Clipboard
Efficacy of early pegylated interferon alpha-2b monotherapy for acute hepatitis C in HIV-infected patients.
De Rosa FG, Mollaretti O, Audagnotto S, De Blasi T, Cariti G, Marucco DM, Bonora S, Perri GD.
De Rosa FG, et al. Among authors: de blasi t.
Clin Infect Dis. 2009 Jun 1;48(11):1636-7. doi: 10.1086/598995.
Clin Infect Dis. 2009.
PMID: 19416030
No abstract available.
Item in Clipboard
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.
Giordanino C, Sacco M, Ceretto S, Smedile A, Ciancio A, Cariti G, De Blasi T, Picciotto A, Marenco S, Grasso A, Pirisi M, Smirne C, Colletta C, Traverso A, Mazzucco D, Ciccone G, Simondi D, Rizzetto M, Saracco G.
Giordanino C, et al. Among authors: de blasi t.
Eur J Gastroenterol Hepatol. 2014 Jan;26(1):52-8. doi: 10.1097/MEG.0b013e328362dc99.
Eur J Gastroenterol Hepatol. 2014.
PMID: 23719564
Item in Clipboard
Severe malaria, artesunate and haemolysis.
Caramello P, Balbiano R, De Blasi T, Chiriotto M, Deagostini M, Calleri G.
Caramello P, et al. Among authors: de blasi t.
J Antimicrob Chemother. 2012 Aug;67(8):2053-4. doi: 10.1093/jac/dks139. Epub 2012 Apr 19.
J Antimicrob Chemother. 2012.
PMID: 22523307
No abstract available.
Item in Clipboard
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group.
Lampertico P, et al.
Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2.
Gut. 2013.
PMID: 22859496
Clinical Trial.
Item in Clipboard
Cite
Cite